0000930413-20-001320.txt : 20200430 0000930413-20-001320.hdr.sgml : 20200430 20200430143812 ACCESSION NUMBER: 0000930413-20-001320 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200430 DATE AS OF CHANGE: 20200430 EFFECTIVENESS DATE: 20200430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RBB FUND, INC. CENTRAL INDEX KEY: 0000831114 IRS NUMBER: 510312196 STATE OF INCORPORATION: MD FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 033-20827 FILM NUMBER: 20835006 BUSINESS ADDRESS: STREET 1: 615 E. MICHIGAN ST. CITY: MILWAUKEE STATE: WI ZIP: 53202 BUSINESS PHONE: 609-731-6256 MAIL ADDRESS: STREET 1: 615 E. MICHIGAN ST. CITY: MILWAUKEE STATE: WI ZIP: 53202 FORMER COMPANY: FORMER CONFORMED NAME: RBB FUND INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: FUND INC /DE/ DATE OF NAME CHANGE: 19600201 0000831114 S000001094 Boston Partners Small Cap Value Fund II C000002982 INSTITUTIONAL BPSIX C000002983 INVESTOR BPSCX 0000831114 S000001097 WPG Partners Small/Micro Cap Value Fund C000002987 INSTITUTIONAL WPGTX 0000831114 S000001106 Boston Partners All-Cap Value Fund C000002997 INSTITUTIONAL BPAIX C000002998 INVESTOR BPAVX 0000831114 S000001108 Boston Partners Long/Short Equity Fund C000003001 INSTITUTIONAL BPLSX C000003002 INVESTOR BPLEX 0000831114 S000030191 Boston Partners Long/Short Research Fund C000092912 Investor Class BPRRX C000092913 Institutional Class BPIRX 0000831114 S000035438 Boston Partners Global Equity Fund C000108833 Investor Class BPGRX C000108834 Institutional Class BPGIX 0000831114 S000040982 Boston Partners Global Long/Short Fund C000127173 Institutional Class BGLSX C000127174 Investor Class BGRSX 0000831114 S000051361 Boston Partners Emerging Markets Long/Short Fund C000161908 Institutional Class BELSX 0000831114 S000058610 Boston Partners Emerging Markets Fund C000192521 Institutional Class BPEMX 0000831114 S000065552 Boston Partners Global Equity Advantage Fund C000212053 Institutional Class BPCIX 497 1 c95764_497.htm

THE RBB FUND, INC.

 

Boston Partners Investment Funds

 

Boston Partners Small Cap Value Fund II – BPSIX
Boston Partners All-Cap Value Fund – BPAIX
Boston Partners Long/Short Equity Fund – BPLSX
Boston Partners Long/Short Research Fund – BPIRX
WPG Partners Small/Micro Cap Value Fund – WPGTX
Boston Partners Global Equity Fund – BPGIX
Boston Partners Global Long/Short Fund – BGLSX
Boston Partners Emerging Markets Long/Short Fund – BELSX
Boston Partners Emerging Markets Fund – BPEMX

Boston Partners Global Equity Advantage Fund – BPCIX

 

 

Supplement dated April 30, 2020

to the Prospectus dated February 28, 2020

 

 

The following replaces the information in the Prospectus section entitled “Additional Information about the Funds’ Investments and Risks – Additional Information About the Funds’ Principal Investments and Risks – Market Risk”:

 

Market Risk. A Fund’s NAV and investment return will fluctuate based upon changes in the value of its investments. The market value of a Fund’s holdings is based upon the market’s perception of value and is not necessarily an objective measure of an investment’s value. There is no assurance that a Fund will realize its investment objective, and an investment in a Fund is not, by itself, a complete or balanced investment program. You could lose money on your investment in a Fund, or a Fund could underperform other investments.

 

Periods of unusually high financial market volatility and restrictive credit conditions, at times limited to a particular sector or geographic area, have occurred in the past and may be expected to recur in the future. Some countries, including the United States, have adopted or have signaled protectionist trade measures, relaxation of the financial industry regulations that followed the financial crisis, and/or reductions to corporate taxes. The scope of these policy changes is still developing, but the equity and debt markets may react strongly to expectations of change, which could increase volatility, particularly if a resulting policy runs counter to the market’s expectations. The outcome of such changes cannot be foreseen at the present time. In addition, geopolitical and other risks, including environmental and public health risks, may add to instability in the world economy and markets generally. As a result of increasingly interconnected global economies and financial markets, the value and liquidity of a Fund’s investments may be negatively affected by events impacting a country or region, regardless of whether the Fund invests in issuers located in or with significant exposure to such country or region.

 

A recent outbreak of respiratory disease caused by a novel coronavirus was first detected in China in December 2019 and has spread internationally. The outbreak has resulted in closing borders and quarantines, enhanced health screenings, cancellations, disrupted supply chains and customer activity, and has produced general concern and uncertainty. The impact of this coronavirus, and other epidemics and pandemics that may arise in the future, could affect national and global economies, individual companies and the market in general in a manner that cannot be foreseen at the present time. Health crises caused by the recent outbreak may heighten other pre-existing political, social and economic risks in a country or region. In the event of a pandemic or an outbreak, there can be no assurance that the Funds and their service providers will be able to maintain normal business operations for an extended period of time or will not lose the services of key personnel on a temporary or long-term basis due to illness or other reasons.  The full impacts of a pandemic or disease outbreaks are unknown, resulting in a high degree of uncertainty for potentially extended periods of time.

 

* * * * *

 

Please retain this supplement for your reference.

 

THE RBB FUND, INC.

 

Boston Partners Investment Funds

 

Boston Partners Small Cap Value Fund II – BPSCX
Boston Partners All-Cap Value Fund – BPAVX
Boston Partners Long/Short Equity Fund – BPLEX
Boston Partners Long/Short Research Fund – BPRRX
Boston Partners Global Equity Fund – BPGRX
Boston Partners Global Long/Short Fund – BGRSX

 

 

Supplement dated April 30, 2020

to the Prospectus dated February 28, 2020

 

 

The following replaces the information in the Prospectus section entitled “Additional Information about the Funds’ Investments and Risks – Additional Information About the Funds’ Principal Investments and Risks – Market Risk”:

 

Market Risk. A Fund’s NAV and investment return will fluctuate based upon changes in the value of its investments. The market value of a Fund’s holdings is based upon the market’s perception of value and is not necessarily an objective measure of an investment’s value. There is no assurance that a Fund will realize its investment objective, and an investment in a Fund is not, by itself, a complete or balanced investment program. You could lose money on your investment in a Fund, or a Fund could underperform other investments.

 

Periods of unusually high financial market volatility and restrictive credit conditions, at times limited to a particular sector or geographic area, have occurred in the past and may be expected to recur in the future. Some countries, including the United States, have adopted or have signaled protectionist trade measures, relaxation of the financial industry regulations that followed the financial crisis, and/or reductions to corporate taxes. The scope of these policy changes is still developing, but the equity and debt markets may react strongly to expectations of change, which could increase volatility, particularly if a resulting policy runs counter to the market’s expectations. The outcome of such changes cannot be foreseen at the present time. In addition, geopolitical and other risks, including environmental and public health risks, may add to instability in the world economy and markets generally. As a result of increasingly interconnected global economies and financial markets, the value and liquidity of a Fund’s investments may be negatively affected by events impacting a country or region, regardless of whether the Fund invests in issuers located in or with significant exposure to such country or region.

 

A recent outbreak of respiratory disease caused by a novel coronavirus was first detected in China in December 2019 and has spread internationally. The outbreak has resulted in closing borders and quarantines, enhanced health screenings, cancellations, disrupted supply chains and customer activity, and has produced general concern and uncertainty. The impact of this coronavirus, and other epidemics and pandemics that may arise in the future, could affect national and global economies, individual companies and the market in general in a manner that cannot be foreseen at the present time. Health crises caused by the recent outbreak may heighten other pre-existing political, social and economic risks in a country or region. In the event of a pandemic or an outbreak, there can be no assurance that the Funds and their service providers will be able to maintain normal business operations for an extended period of time or will not lose the services of key personnel on a temporary or long-term basis due to illness or other reasons.  The full impacts of a pandemic or disease outbreaks are unknown, resulting in a high degree of uncertainty for potentially extended periods of time.

 

* * * * *

 

Please retain this supplement for your reference.

 

THE RBB FUND, INC.

 

Boston Partners Investment Funds

 

Boston Partners Small Cap Value Fund II
Boston Partners All-Cap Value Fund
Boston Partners Long/Short Equity Fund
Boston Partners Long/Short Research Fund
WPG Partners Small/Micro Cap Value Fund
Boston Partners Global Equity Fund
Boston Partners Global Long/Short Fund
Boston Partners Emerging Markets Long/Short Fund
Boston Partners Emerging Markets Fund
Boston Partners Global Equity Advantage Fund

 

 

Supplement dated April 30, 2020

to the Statement of Additional Information (“SAI”) dated February 28, 2020

 

 

The following supplements the information in the SAI section entitled “Principal Investment Instruments and Policies”:

 

Pandemic Risk

Disease outbreaks that affect local economies or the global economy may materially and adversely impact the Funds and/or the Adviser’s (or a Co-Adviser’s) business.  For example, uncertainties regarding the novel Coronavirus (“COVID-19”) outbreak have resulted in serious economic disruptions across the globe. These types of outbreaks can be expected to cause severe decreases in core business activities such as manufacturing, purchasing, tourism, business conferences and workplace participation, among others. These disruptions lead to instability in the market place, including stock market losses and overall volatility, as has occurred in connection with COVID-19. In the face of such instability, governments may take extreme and unpredictable measures to combat the spread of disease and mitigate the resulting market disruptions and losses.  The Adviser or a Co-Adviser has in place business continuity plans reasonably designed to ensure that it maintains normal business operations, and it periodically tests those plans. However, in the event of a pandemic or an outbreak, there can be no assurance that the Adviser, a Co-Adviser, or the Funds’ service providers will be able to maintain normal business operations for an extended period of time or will not lose the services of key personnel on a temporary or long-term basis due to illness or other reasons. The full impacts of a pandemic or disease outbreaks are unknown, resulting in a high degree of uncertainty for potentially extended periods of time.

 

* * * * *

 

Please retain this supplement for your reference.